Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

P&G describes quinolonyl-cephem dithiocarbamates

Oct. 4, 1996

Cephalosporin-bridged carbacephem combinations evaluated by Roche

Oct. 4, 1996

Combined beta-lactamase inhibitor/antibacterial agent from Roche

Oct. 4, 1996

Bridged carbacephems from Roche for use in combination with cephalosporins

Oct. 4, 1996

Fujisawa describes orally active cephalosporin

Oct. 4, 1996

Hydroxypyridone cephalosporins described by Kyorin

Oct. 4, 1996

New antiacne bacteriocin

Oct. 4, 1996

Antihyperglycemic agents from Wyeth-Ayerst

Sep. 27, 1996

Yamanouchi reports agent for urinary incontinence

Sep. 27, 1996

gpIIb/IIIa antagonist selected for clinical evaluation at DuPont Merck

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...